Pfizer Says COVID-19 Pill Near 90% Protective Against Hospitalization, Death

NEW YORK — Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. Read More